Korro Bio (KRRO) Enterprise Value Growth (1y) (2019 - 2026)
Korro Bio (KRRO) Enterprise Value Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.86% |
| Dec 31, 2025 | 40.40% |
| Sep 30, 2025 | 32.50% |
| Jun 30, 2025 | 38.79% |
| Mar 31, 2025 | 19.25% |
| Dec 31, 2024 | 25.72% |
| Sep 30, 2024 | -228.35% |
| Jun 30, 2024 | -238.73% |
| Mar 31, 2024 | -113.58% |
| Dec 31, 2023 | -359.62% |
| Sep 30, 2023 | 58.00% |
| Jun 30, 2023 | 58.13% |
| Mar 31, 2023 | 43.21% |
| Dec 31, 2022 | 71.74% |
| Sep 30, 2022 | 32.91% |
| Jun 30, 2022 | 34.27% |
| Mar 31, 2022 | 39.79% |
| Dec 31, 2021 | 40.68% |
| Sep 30, 2021 | 33.96% |
| Jun 30, 2021 | 13.56% |